Abstract
Only a small percentage of patients with pancreatic cancer have limited disease suitable for curative resection. Even with surgery, patients often have poor long-term survival due to relapse of the disease. There are controversies about the adjuvant treatment of these patients. We reported the survival of resected pancreatic cancer from a single institute. About 128 consecutive patients who had complete resection of the pancreatic ductal adenocarcinoma were evaluated, retrospectively. Chemoradiotherapy (45 Gy plus 5-fluorouracil) was given to 63 patients. Fifty-five patients declined to take chemoradiotherapy or with poor performance status were observed without additional treatment. Eight patients took only chemotherapy and two patients took only radiotherapy. The median survival of chemoradiotherapy group was significantly higher than the observation group (13 months vs. 4 months, respectively; P < 0.001). In multivariate analyses the most important factors improving survival were the application of chemoradiation (P < 0.001), low-level serum LDH (P = 0.026), good performance status (P = 0.033) and low serum CA19-9 (P = 0.037). Although adjuvant chemoradiotherapy has a significant survival benefit when compared with the observation group, the survival data are still poor for pancreatic cancer. Therefore, we need more effective additional or adjuvant treatment modalities.
Similar content being viewed by others
References
Bramhall SR, et al. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995;82:111–5
Jemal A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5–26
Ghaneh P, et al. Adjuvant therapy in pancreatic cancer. World J Gastroenterol 2001;7:482–9
Tsai JY, Iannitti DA, Safran H. Combined modality therapy for pancreatic cancer. Seminars in Oncology 2003;4(Suppl 9):71–9
Neoptolemos JP, et al. Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol 2003;14:675–92
Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899–903
Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003;237:74–85
Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100313 patients diagnosed from 1985–1995, using the National Center Database. J Am Coll Surg 1999;189:1–7
Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899–903
Klinkenbijl JH, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776–84
Bakkevold KE, Amesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas, papilla of Vater-results of a controlled, prospective, randomized multicenter study. Eur J Cancer 1993;29A:698–703
Takada T, et al. Is postoperative adjuvant chemotherapy usefull for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002;95:1685–95
Chua YJ, Cunningham D. Adjuvant treatment for resectable pancreatic cancer. J Clin Oncol 2005;23:4532–7
Neoptolemos JP, et al. A randomized trial of chemotherapy and chemotherapy after resection of pancreatic cancer. N Eng J Med 2004;350:1200–10
Foo ML, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation±5 fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483–9
Mehta VK, et al. Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 2000;48:1483–7
Garofalo M, Flannery T, Regine W. The case for adjuvant chemoradiation for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:403–16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yazar, A., Üstüner, Z., Şakar, B. et al. Adjuvant chemoradiation for patients with adenocarcinoma of the pancreas: an expirence of single institute. Med Oncol 24, 384–387 (2007). https://doi.org/10.1007/s12032-007-0032-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-007-0032-x